Auransa

📍 Palo Alto, United States👥 11 employees💰 Last funded Aug 2020
Biotechnology Research🌐 auransa.com
Website LinkedIn
We are a clinical-stage, AI-native biopharma that mines massive data for therapeutic gold to raise the standard of cancer care. Our platform uses AI and available, heterogenous human disease data to uncover novel drug candidates for the most responsive patients, leading to smarter drug discovery that maximizes clinical trial success. We are currently focused on advancing better therapies for cancers and cancer-related diseases. Our lead program, AU-409, for liver cancer, is in Phase 1 clinical studies.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2014–2020 · investors recorded per year
201412015120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Auransa?
Auransa has 3 investors on record on gritt.io.
When did Auransa last raise funding?
The most recent investment in Auransa recorded on gritt.io was in August 2020.
What industry is Auransa in?
Auransa operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Auransa based?
Auransa is headquartered in Palo Alto, United States.